Cargando…
HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know
Patients with Systemic Lupus Erythematosus (SLE) are at increased risk for infections. Vaccination is a powerful tool to prevent infections, even in immunocompromised patients. Most non-live vaccines are immunogenic and safe in patients with SLE, even if antibody titres are frequently lower than tho...
Autores principales: | Grein, Ingrid Herta Rotstein, Groot, Noortje, Lacerda, Marcela Ignacchiti, Wulffraat, Nico, Pileggi, Gecilmara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782298/ https://www.ncbi.nlm.nih.gov/pubmed/26956735 http://dx.doi.org/10.1186/s12969-016-0072-x |
Ejemplares similares
-
Long-term outcomes in childhood-onset systemic lupus erythematosus: preliminary results of the CHILL-NL study
por: Groot, Noortje, et al.
Publicado: (2014) -
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study
por: Grein, Ingrid Herta Rotstein, et al.
Publicado: (2020) -
Analysis of rituximab’s usage for the treatment of pediatric systemic lupus erythematosus
por: Alves, Alessandra, et al.
Publicado: (2014) -
SHARE – workpackage 5 : evidence based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus
por: Groot, Noortje, et al.
Publicado: (2014) -
Vaccinations in Paediatric Rheumatology: an Update on Current Developments
por: Groot, Noortje, et al.
Publicado: (2015)